Leaf411 Renews Appeal to Help Patients Across the Country Afford Medical Cannabis
In late 2022, Leaf411, a cannabis-trained nurse guidance service, announced that they resumed their affordability program for patients struggling to pay for their medicine. In a recent update, Leaf411 outlined their continued response to requests for assistance they are receiving from across the country.
According to a recent press release, Leaf411 sought to raise awareness about concerns they are hearing from patients across the country around the ability to afford medical cannabis. Last November, Leaf411 resumed their Affordability Program, which connects participating patients with free or low-cost donated cannabis products (1). Now the nation’s first no- or low-cost cannabis nurse guidance call service worries economic downturns in 2023 will increase the struggle for low-income patients to afford their medicine.
“Our recently relaunched Affordability Program has seen a huge increase in demand with 500 new applicants in the last 60 days and we are unable to meet many patient requests due to a lack of available products,” said Katherine Golden, CEO of Leaf411, in a press release (2). “We expect that demand for these services will continue to rise in 2023 as the economy struggles.”
According to the press release, costs of utilizing cannabis as medicine can include fees for obtaining a medical card and consultations with a cannabis clinician in addition to the cost of the medicine itself (2). Leaf411 says the fee for their scheduled guidance calls are a suggested $25 donation, and only 17% of callers are able to afford that (2).
“Unlike patients who benefit from insurance or other assistance programs to help pay for prescription pharmaceuticals, cannabis patients have almost no such resources—and those programs that exist are increasingly underfunded,” Golden continued (2). “The industry has spent a great deal of energy and time educating the public about cannabis medicine, but we are far behind in supporting the programs and services that support education and greater access. The economic challenges of the coming year will unfortunately expose just how vulnerable these patients are and why industry assistance programs need stronger support.”
Patients interested in participating in the Leaf411 Affordability Program can complete an application here.
Cannabis businesses interested in donating products to the program should contact Leaf411 at affordability@leaf411.org.
To learn more about the program, visit the Leaf411 website.
References
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.
Ep 23, Part III: Accreditation in the Cannabis Industry with Susan Audino
October 24th 2024In Part III of this episode, host Evan Friedmann is joined by Susan Audino, PhD, founder of S.A. Audino & Associates, LLC, and co-founder of Saturn Scientific, LLC, to examine the complexities of sampling in the cannabis industry, emphasizing the need for proper sampling plans, and methods.
